BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30969932)

  • 41. Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines.
    De Kegel B; Quinn N; Thompson NA; Adams DJ; Ryan CJ
    Cell Syst; 2021 Dec; 12(12):1144-1159.e6. PubMed ID: 34529928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SANA: cross-species prediction of Gene Ontology GO annotations via topological network alignment.
    Wang S; Atkinson GRS; Hayes WB
    NPJ Syst Biol Appl; 2022 Jul; 8(1):25. PubMed ID: 35859153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SL-Miner: a web server for mining evidence and prioritization of cancer-specific synthetic lethality.
    Liu X; Hu J; Zheng J
    Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38244572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of synthetic lethal pairs in biological systems through network information centrality.
    Kranthi T; Rao SB; Manimaran P
    Mol Biosyst; 2013 Aug; 9(8):2163-7. PubMed ID: 23728082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-view graph convolutional network for cancer cell-specific synthetic lethality prediction.
    Fan K; Tang S; Gökbağ B; Cheng L; Li L
    Front Genet; 2022; 13():1103092. PubMed ID: 36699450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In silico prediction of synthetic lethality by meta-analysis of genetic interactions, functions, and pathways in yeast and human cancer.
    Wu M; Li X; Zhang F; Li X; Kwoh CK; Zheng J
    Cancer Inform; 2014; 13(Suppl 3):71-80. PubMed ID: 25452682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
    Weng S; Ruan H
    FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SLKB: synthetic lethality knowledge base.
    Gökbağ B; Tang S; Fan K; Cheng L; Yu L; Zhao Y; Li L
    Nucleic Acids Res; 2024 Jan; 52(D1):D1418-D1428. PubMed ID: 37889037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
    Zangene E; Marashi SA; Montazeri H
    Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MAGCN: A Multiple Attention Graph Convolution Networks for Predicting Synthetic Lethality.
    Lu X; Chen G; Li J; Hu X; Sun F
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(5):2681-2689. PubMed ID: 36374879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novelty Indicator for Enhanced Prioritization of Predicted Gene Ontology Annotations.
    Chicco D; Palluzzi F; Masseroli M
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):954-965. PubMed ID: 28436884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting drug synergy for precision medicine using network biology and machine learning.
    Cuvitoglu A; Zhou JX; Huang S; Isik Z
    J Bioinform Comput Biol; 2019 Apr; 17(2):1950012. PubMed ID: 31057072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
    Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
    Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MPASL: multi-perspective learning knowledge graph attention network for synthetic lethality prediction in human cancer.
    Zhang G; Chen Y; Yan C; Wang J; Liang W; Luo J; Luo H
    Front Pharmacol; 2024; 15():1398231. PubMed ID: 38835667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TP53 mutations, expression and interaction networks in human cancers.
    Wang X; Sun Q
    Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survey: Enhancing protein complex prediction in PPI networks with GO similarity weighting.
    Price T; Peña FI; Cho YR
    Interdiscip Sci; 2013 Sep; 5(3):196-210. PubMed ID: 24307411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ELISL: early-late integrated synthetic lethality prediction in cancer.
    Tepeli YI; Seale C; Gonçalves JP
    Bioinformatics; 2024 Jan; 40(1):. PubMed ID: 38113447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tumor therapy landscape of synthetic lethality.
    Zhang B; Tang C; Yao Y; Chen X; Zhou C; Wei Z; Xing F; Chen L; Cai X; Zhang Z; Sun S; Liu Q
    Nat Commun; 2021 Feb; 12(1):1275. PubMed ID: 33627666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NMFGO: Gene Function Prediction via Nonnegative Matrix Factorization with Gene Ontology.
    Yu G; Wang K; Fu G; Guo M; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(1):238-249. PubMed ID: 30059316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
    Markowska M; Budzinska MA; Coenen-Stass A; Kang S; Kizling E; Kolmus K; Koras K; Staub E; Szczurek E
    Sci Rep; 2023 Apr; 13(1):7049. PubMed ID: 37120674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.